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ABSTRACT Proteins that bend DNA are important
regulators of biological processes. Sequence-specific DNA
bending ligands have been designed that bind two noncon-
tiguous sites in the major groove and induce a bend in the
DNA. An oligonucleotide containing pyrimidine segments
separated by a central variable linker domain simulta-
neously binds by triple helix formation two 15-bp purine
tracts separated by 10 bp. Bend angles of 610, 500, and 380
directed towards the minor groove were quantitated by
phasing analysis for linkers of four, five, and six T residues,
respectively. The design and synthesis of nonnatural archi-
tectural factors may provide a new class of reagents for use
in biology and human medicine.
DNA bending proteins play a role in site-specific recombi-
nation, transposition, replication, viral integration, and tran-
scription (1-12). At least three different mechanisms for
protein-DNA bending have emerged. These include wedging
intercalating groups into the helix (13-15), binding at two
distal sites and looping the DNA around the protein (16-18),
and charge neutralization at the phosphodiester backbone
(19-21). These proteins are important both for locally
distorting DNA at that site and for global molding of DNA
conformation to promote the binding and action of distal
factors. The design of nonnatural site-specific DNA bending
ligands could be envisioned through one of the mechanisms
used by proteins.
Oligonucleotide-directed triple helix formation is a general
method for the sequence-specific recognition of double helical
DNA. Two classes of triple helix forming oligonucleotides have
been identified (22-26). In one class, pyrimidine oligonucle-
otides bind double helical DNA in the major groove parallel to
the purine tract through the formation of specific Hoogsteen
hydrogen bonds (22-36). Using triple helix formation forDNA
recognition in the major groove, a bifunctional oligonucleotide
was designed to mimic a DNA bending protein. DNA bending
was accomplished by binding two distal DNA sites separated
by 10 bp with oligonucleotides 1-6 containing two DNA-
binding domains at the 5' and 3' ends connected by a variable
spacer (see Fig. 1).
MATERIALS AND METHODS
General. Phosphoramidites were purchased from Glen
Research (Sterling, VA) and BioGenex Laboratories (San
Ramon, CA). DNA synthesis was performed using standard
methods on an Applied Biosystems model 380B DNA syn-
thesizer. Oligonucleotide purification was performed on a
Pharmacia fast protein liquid chromatography using Pro-
RPC reverse phase and Mono Q anion exchange columns.
Enzymes were purchased from Boehringer Mannheim with
the exception of Sequenase 2.0, which was purchased from
United States Biochemical. Deoxyadenosine 5 '-[a-
32P]triphosphate was obtained from Amersham. Storage
Phosphor autoradiography was performed using a Molecular
Dynamics model 400S Phosphorimager and IMAGEQUANT
software (National Institutes of Health, Bethesda). Autora-
diography used Kodak X-OMAT AR film without an inten-
sifying screen.
Preparation of Labeled DNA. For the circular permutation
assay, 101-bp 3'-end labeled restriction products were gener-
ated by digestion with the designated restriction enzyme and
simultaneously filled in with Sequenase 2.0, deoxyadenosine
5'a-[c-32P]triphosphate, and nonradioactive deoxynucleoside
triphosphates. The 101-bp fragment was isolated by nondena-
turing 5% PAGE and the purified fragment was treated with
proteinase K, filtered, further extracted with phenol/
chloroform, and precipitated with ethanol. The 577-585-bp
fragments for phasing assays were generated by cleavage of
pUC19 derived plasmids with NdeI and SapI (New England
Biolabs) and purified as above.
Quantitative DNase I Footprint Titrations. The binding
energy was calculated from the equilibrium association con-
stants of the oligonucleotides 5'-TCTCTCCTCCTCTCT-3'
and 5'-TCCTCTCTCTCTCCT-3' (where C is 5-methyl cyto-
sine) binding to their cognate sites by quantitative DNase I
footprint titrations. The values reported are the mean value of
four footprint titration experiments ± SEM. Oligonucleotide
titrations were performed at 22°C, pH 5.5, in the presence of
45 mM Mes, 1 mM MgCl2, and 32P-3'-end-labeled target DNA
and allowed to equilibrate for at least 24 hr before footprinting.
Footprinting reactions and data analysis were carried out as
described (27, 37).
Gel-Shift Assay. The gel-shift assay was performed by
equilibrating samples for at least 1 hr at 22°C, pH 5.5, with 10
p,M oligonucleotide, 45 mM Mes, 1 mM MgCl2, and 32p-3'-
end-labeled EcoRI cut target DNA in a vol of 10 ,ul. One
microliter of 15% glycerol loading buffer was then added.
Samples were run on a 10% polyacrylamide gel at 4°C, pH 5.5,
with a 75:1 acrylamide/bis-acrylamide ratio in 45 mM Mes and
1 mM MgCl2 with buffer recirculation.
Circular Permutation Analysis. Circular permutation anal-
ysis was performed under similar gel-shift conditions. Exper-
iments were performed with equilibrations at 22°C, pH 5.5,
with 45 mM Mes and 1 mM MgCl2 containing 20 ,uM
oligonucleotide.
Phasing Analysis. Phasing analysis was performed on 577-
585-bp fragments where the intrinisically curved sequence
5'-AAAAAACGGCAAAAAACGGGCAAAAAA-3' was
linked by a variable G+C tract to the target sequence.
Equilibrations were performed as in the gel-shift assay with an
oligonucleotide concentration of 10 ,uM under similar elec-
trophoretic conditions with a 7% polyacrylamide gel and a 32:1
acrylamide/bis-acrylamide ratio.
Quantitation of Bend Angle. Bend angle quantitation was
based on previously described methods (21, 38-40). Briefly,
the relationship between the distance migrated and fragment
size for molecular weight standards was plotted and fit to a
logarithmic function (41). This was used to determine the
relative mobilities of the various bent fragments, which were
plotted and fit to the cosine function Ay= Ilave{Aph/
2[cos(2iir(S-ST/Pph))1 + 1}, where p. is the electrophoretic
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mobility measured in apparent base pairs (RL), Aph is the
phasing amplitude, S is the distance between bend centers,
ST is the out of phase bend center distance, and Pph is the
phasing period (21, 40). The bend angle, aB, was then
determined from the geometrically derived phasing function
tan(kaB/2) = (Aph/2)/tan(kac/2) where ac is the A tract
bend angle (21, 40). A standardization value, k, for electro-
phoretic conditions was calculated to be 1.20 ± 0.11 using
fragments that were retarded only by the inserted A tract (21,
40). The fragment, in addition to the inserted A tract, was
found to have an intrinsic curvature of 180 ± 0.4°, which was
2.3 ± 0.1 bp out of phase with the target site. The additional
intrinsic fragment bend angle in the same plane was sub-
tracted from the obtained angle to yield the bend angle of the
structure.
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RESULTS AND DISCUSSION
Two 15-bp purine tracts separated by one turn of the DNA
helix (10 bp) were targeted by oligonucleotides 1-6 containing
two pyrimidine tracts (T and MeC) connected by a central T
linker of varying size. Previous studies have demonstrated that
nonadjacent purine tracts can be bound simultaneously, but
the influence of oligonucleotide length and sequence compo-
sition on bend angle was not examined (42, 43). To allow
bending of DNA, the binding energies of the two third strand
oligonucleotides must be greater than the energetic penalty for
bending. The equilibrium association constant, Keq, of 15-mer
oligonucleotide 7, 5'-TMeCTMeCTMeCMeCTMeCMeCTMe
CTMeCT-3' (targeted to site A) was measured as Keq = 2.2 ±
0.2 x 107 M-1, while that for 15-mer oligonucleotide 8,
5'-TMeCmeCTMeCTMeCTMeCTMeCTMeCMeCT-3' (targeted to
site B) was measured as Keq = 1.7 + 0.1 x 107 M-1 by
quantitative DNase I footprint titration methods at 22°C and
pH 5.5 (Fig. 1). From these equilibrium association constants,
the binding energies of oligonucleotides bound at site A and
site B were calculated as -10.0 ± 0.1 kcal/mol and -9.9 ± 0.1
kcal/mol, respectively.
DNA bending as a function of linker size was initially
screened using a circular permutation assay (44). This assay
is based upon the theory that DNA mobility is directly
related to the mean square end-to-end distance for frag-
ments of the same size (45). A bending target site was cloned
between tandem polylinkers into pUC19. Cleavage with
various restriction enzymes gave a series of 101-bp fragments
in which the target site is located at various positions. As the
bend site is moved through the fragment, the end-to-end
distance changes.
The sequence specific binding ligands can bind as one
oligonucleotide bound to two sites (bent), one oligonucleotide
bound to one site (Y), or as two oligonucleotides bound to two
sites (double Y). Control oligonucleotides 9 and 10 contain a
mismatch in one of the triplex sites and only bind to one of the
two designated target sites. Oligonucleotide 4, which contains
two pyrimidine tracts separated by a central T4 linker, reveals
VP6
1 5' TCTrTgTCCTCT 3'
2 5' TCTCTMTCTCTCTTTTQC,TCTjTCTMT 3'
3 5' TCTCTCCTgCTCTCTTTTTUTCTCTCTCTCCT 3'
4 5' TQTQT9T(ZCTTTTTTTTQTQTQTQTQTCCT 3'
5 5' TCT£TCCTCCTCTCTTTTTTTCSTgTCTCTCTCCT 3'
6 5' TCTCTMTTTC:TTTTTTTTCTCTCT5TaT!:CT 3'
7 5' TUCTCTCCTCTTCT 3
8 5 TCCTCTCTCTCTCCT 3'
9 5 TCTCTCCTCCTCTCTTTTTTTTTTTTTTTT 31
10 5' TTTTTTTTTTTTTTTTCCTTCTCTCTCCT 3'
FIG. 1. Circular permutation analysis of ligand induced bending.
The 101-bp probes used for circular permutation analysis were gen-
erated by restriction enzyme cleavage at sites within tandem polylink-
ers surrounding the ligand binding site. The plasmid contains the
sequence 5'-GAATTCGAGCTCGGTACCCGGGGATCCTCTAG-
AGTCGACCTGCAGGCATGCAAGCTTAGAGAGGAGG-
AGAGAGCGGTGCGGTAGGAGAGAGAGAG-
GAGAATTCGAGCTCGGTACCCGGGGATC-
CTCTAGAGTCGACCTGCAGGCATGCAAGCTT-3'. The ligands
designed to bend DNA sequence specifically were two third strand
oligonucleotide domains containing 5-methyl C (indicated by C) and
T residues linked by a variable number of T residues.
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FIG. 2. PhosphorImage using a linear dynamic range of 50 of a
10% (75:1 acrylamide/bis ratio) polyacrylamide gel run in 45 mM
Mes, 1 mM MgCl2, pH 5.5 at 4°C showing a gel-shift analysis of
oligonucleotides 4, 9, and 10. The EcoRI and XbaI fragments from
Fig. 1, with the triple helix target sites near the termini and near the
center, respectively, were generated and 3'-end-labeled with 32p.
Oligonucleotides were incubated at a concentration of 5 ,uM at 22°C
at pH 5.5, with 45 mM Mes and 1 mM MgCl2. Lanes 1 and 6 show
the EcoRI and XbaI fragments, respectively, incubated without
oligonucleotide. Lanes 2 and 7 show the gel-shift generated by
oligonucleotide 4, with the bent fragment indicated by an asterisk.
Lanes 3 and 8 depict this for oligonucleotide 9, lanes 4 and 9 for
oligonucleotide 10, and lanes 5 and 10 for an incubation with both
oligonucleotides 9 and 10.
-
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that it is not bound as a Y or as a double Y (Fig. 2). Addition
of control oligonucleotides 9 and 10 affords both the Y and
double Y structures. In addition, mobilities of the Y and
double Y structures are unchanged between the EcoRI and
XbaI fragments shown on both sides of Fig. 2, indicating no
induced DNA bend.
Circular permutation analysis of the bent structures shows
significant position-dependent anomalous mobility as a func-
tion of linker length. Oligonucleotides with shorter linkers
yield larger bend angles (Fig. 3). A three T spacer appears to
be the minimal linker where a majority of the molecular
ensemble is in the bent conformation under these conditions.
As the linker size is further shortened, a decreasing proportion
of the molecular ensemble is found as the bent structure with
a concomitant increase in the populations of Y and double Y
species. A range of bend angles of differing magnitude can be
produced and the linker size can be tuned to yield the
magnitude of the desired bend angle.
The circular permutation assay has been found to over-
estimate bend angles where other factors such as increased
DNA flexibility or binding of a ligand that is large compared
with the target duplex affect migration (21, 46). While such
complicating effects are not anticipated in this experimental
design, a phasing analysis was used to measure the bend
angles of oligonucleotides 4-6 (Fig. 4A) (38). The A tract
used in this experiment has a bend angle of 540 and oligo-
nucleotides 4-6 were found to provide bend angles of 610 ±
2.70, 50° + 1.00, and 380 +±0.5, respectively (Fig. 4 B and C
and Table 1) (47). Phasing analysis also provides information
on bend direction. The bend was found to be centered in the
middle of the intervening duplex directed towards the minor
groove.
To form the bent structure, the third strand oligonucleotide
most likely binds initially at a single site. The DNA then must
show sufficient dynamic flexibility to allow binding of the
second domain. The final structure obtained is a function of
the energetic difference between the binding energy of the
third strand and the requisite bending energy caused by
constriction of the DNA. The thermodynamically favored
structure occurs where this difference is greatest, with other
structures populated dependent upon their relative energetic
differences. The energetic cost of bending DNA can be
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FIG. 3. Autoradiogram of a 10% (75:1 acrylamide/bis ratio)
polyacrylamide gel run in 45 mM Mes and 1 mM MgCl2 at pH 5.5 and
at 4°C showing circular permutation analysis of bending using oligo-
nucleotides 1-5. EcoRI, XbaI, and HindlIl fragments from Fig. 1 were
generated and 3'-end-labeled with 32p. Oligonucleotides were incu-
bated at a concentration of 20 ,uM at 22°C, with 45 mM Mes and 1 mM
MgCl2 at pH 5.5. Lanes 1-3 show the EcoRI, XbaI, and Hindlll
fragments, respectively, incubated without oligonucleotide. Lanes 4-6
show oligonucleotide 5 incubated with the EcoRI, XbaI, and Hindlll
fragments, respectively. Lanes 7-9 depict oligonucleotide 4 binding to
the three fragments, respectively, while lanes 10-12 depict this for
oligonucleotide 3, lanes 13-15 depict this for oligonucleotide 2, and
lanes 16-18 depict this for oligonucleotide 1. Bent fragments are
indicated with an asterisk.
4
36 38 40 42 44 46 48 50
phasing distance
FIG. 4. (A) General schematic for phasing analysis ofDNA bending.
A set of three phased A6 tracts with total bend angle of 54° is separated
by the phasing dist-ance from a second bend. (B) Autoradiogram of a 7%
(32:1 acrylamide/bis ratio) polyacrylamide gel run in 45 mM Mes and, 1
mM MgCl2 at pH 5.5 and at 4°C showing phasing analysis of bending
oligonucleotides 4-6. The 577-585-bp fragments generated by simulta-
neous SapI/NdeI cleavage were 3'-end-labeled with 32p. Oligonucleotides
were incubated at a concentration of 10 /xM at 22°C and at pH 5.5 with
45 mM Mes and 1mM MgCl2. Lanes 1-4 depict the four phasing fragments
with phasing distances of 40, 42, 45, and 48 respectively with no oligonu-
cleotide present while lanes 5-8 depict the respective fragments with
oligonucleotide 6 bound, lanes 9-12 with oligonucleotide 5 bound, and
lanes 13-16 with oligonucleotide 4 bound. (C) Phasing diagram for
oligonucleotides 4-6. The mobilities of these oligonucleotides were plotted
against the phasing distance and fit to a standard cosine function (21).
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Table 1. Bend angles measured by phasing analysis for triple
helical structures with variable linker sizes at pH 5.5 with
oligonucleotides containing 5-methyl C and T
Oligonucleotide Linker size Bend angle
4 4 610 2.70
5 5 500 1.00
6 6 380 0.50
Error values reported are the standard error of the mean. The
error limits on the bend angles likely do not reflect the semiquan-
titative nature of the analysis and should be considered minimum
values.
estimated by modeling DNA as a smoothly bending worm-like
chain with coulombic repulsion from phosphates placed at
fixed distances (48, 49). Assuming the third strand is fully
hydrogen bonded and ignoring cooperative effects, this model
predicts a bend angle of 860 to promote equal ratios ofbent and
straight DNA for an oligonucleotide with a calculated binding
energy of -9.9 kcal/mole. Circular permutation analysis re-
veals a single bent structure that decreases in population as the
linker length decreases but remains populated at a length of a
single T residue (Fig. 3). For a linker of three T residues, the
ratio of bent to straight DNA is approximately one. The bend
angle of this structure was too high to measure accurately using
phasing analysis and a four T linker was the smallest that was
characterized quantitatively, with a bend angle of 610. A ribbon
model that depicts a bent structure with a four base linker is
shown in Fig. 5. This model is bent towards the minor groove
at the center of the intervening duplex, with the four T linker
of the third strand pulled taut away from the duplex and
unstacked.
3'
FIG. 5. Ribbon model of bent structure formed by oligonucleotide
4. Two 15-bp triple helices are connected by a four T linker spanning
the intervening 10 bp of double helix. This region is bent towards the
minor groove in the center.
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